Crystal structures of the calcium pump and sarcolipin in the Mg 2+-bound E1 state

Nature

Volumn 495, Issue 7440, 2013, Pages 260-264

  Toyoshima, Chikashi ^a   Iwasawa, Shiho ^a   Ogawa, Haruo ^a   Hirata, Ayami ^a   Tsueda, Junko ^a   Inesi, Giuseppe ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); MAGNESIUM ION; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

AMINO ACID; CALCIUM; CONCENTRATION (COMPOSITION); CRYSTAL STRUCTURE; INHIBITION; INHIBITOR; ION; LAGOMORPH; MAGNESIUM; MEMBRANE; MUSCLE; PHYSIOLOGICAL RESPONSE;

ARTICLE; AUTOPHOSPHORYLATION; BINDING SITE; CALCIUM BINDING; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THERMOGENESIS;

ANIMALS; BINDING SITES; CALCIUM-BINDING PROTEINS; CELL MEMBRANE; CRYSTALLOGRAPHY, X-RAY; MAGNESIUM; MODELS, MOLECULAR; MUSCLE PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEOLIPIDS; RABBITS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

ORYCTOLAGUS CUNICULUS;

EID: 84874957001     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11899     Document Type: Article

References (42)

1. 2+- ATPaseofsarcoplasmic reticulum. Arch. Biochem. Biophys. 476, 3-11 (2008).
2. 2+-ATPase: design of a perfect chemi-osmotic pump. Q. Rev. Biophys. 43, 501-566 (2010).
3. 2+-ATPase. J. Biol. Chem. 281, 37720-37727 (2006).
4. Champeil, P., Gingold, M. P., Guillain, F. & Inesi, G. Effect of magnesium on the calcium-dependent transient kinetics of sarcoplasmic reticulum ATPase, studied bystoppedflow fluorescenceand phosphorylation. J. Biol. Chem. 258, 4453-4458 (1983).
5. 2+ binding sitesby charge transfer. J. Mol. Biol. 391, 858-871 (2009).
6. Odermatt, A. et al. Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics 45, 541-553 (1997).
7. 2+-ATPase. J. Biol. Chem. 273, 12360-12369 (1998).
8. MacLennan, D. H. & Kranias, E. G. Phospholamban: a crucial regulator of cardiac contractility. Nature Rev. Mol. Cell Biol. 4, 566-577 (2003).
9. 2+ATPasepumpexpressionanditsrelevancetocardiacmusclephysiologyand pathology. Cardiovasc. Res. 77, 265-273 (2008).
10. Kranias, E. G. & Hajjar, R. J. Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ. Res. 110, 1646-1660 (2012).
11. Bal, N. C. et al. Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals. Nature Med. 18, 1575-1579 (2012).
12. 2+. Proc. Natl Acad. Sci. USA 102, 14489-14496 (2005).
13. Jensen, A. M., Sorensen, T. L., Olesen, C., Møller, J. V. & Nissen, P. Modulatory and catalytic modes of ATP binding by the calcium pump. EMBO J. 25, 2305-2314 (2006).
14. Toyoshima, C. & Nomura, H. Structural changes in the calcium pump accompanying the dissociation of calcium. Nature 418, 605-611 (2002).
15. Toyoshima, C., Nomura, H. & Tsuda, T. Lumenal gating mechanism revealed in calciumpumpcrystalstructureswithphosphate analogues. Nature 432, 361-368 (2004).
16. Lübben, M. et al. Sulfate acts as phosphate analog on the monomeric catalytic fragment of the CPx-ATPase CopB from Sulfolobus solfataricus. J. Mol. Biol. 369, 368-385 (2007).
17. 2+. Proc. Natl Acad. Sci. USA 108, 1833-1838 (2011).
18. Holloway, C. E. & Melnik, M. Magnesium compounds: classification and analysis of crystallographic and structural data. J. Organomet. Chem. 465, 1-63 (1994).
19. 2+. J. Biol. Chem. 268, 17018-17025 (1993).
20. Afara, M. R., Trieber, C. A., Ceholski, D. K. & Young, H. S. Peptide inhibitors use two related mechanisms to alter the apparent calcium affinity of the sarcoplasmic reticulum calcium pump. Biochemistry 47, 9522-9530 (2008).
21. Bhupathy, P., Babu, G. J., Ito, M. & Periasamy, M. Threonine-5attheN-terminuscan modulate sarcolipin functionincardiac myocytes. J. Mol. Cell. Cardiol. 47, 723-729 (2009).
22. 2+ transport and muscle relaxation in skeletal muscle from sarcolipin-null mice. Am. J. Physiol. Cell Physiol. 301, C841-C849 (2011).
23. 2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban. Proc. Natl Acad. Sci. USA 100, 5040-5045 (2003).
24. 2+ ATPase. Proc. Natl Acad. Sci. USA 100, 467-472 (2003).
25. 2+ pumpof cardiac sarcoplasmic reticulum toprobe spatial and functional interactions within the transmembrane domain. J. Biol. Chem. 281, 14163-14172 (2006).
26. 2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state. J. Biol. Chem. 285, 28540-28552 (2010).
27. Bidwell, P., Blackwell, D. J., Hou, Z., Zima, A. V. & Robia, S. L. Phospholamban binds with differential affinity to calcium pump conformers. J. Biol. Chem. 286, 35044-35050 (2011).
28. Buffy, J. J. et al. Defining the intramembrane binding mechanism of sarcolipin to calcium ATPase using solution NMR spectroscopy. J. Mol. Biol. 358, 420-429 (2006).
29. Olesen, C., Sørensen, T. L., Nielsen, R. C., Møller, J. V. & Nissen, P. Dephosphorylationofthe calcium pumpcoupledtocounterion occlusion. Science 306, 2251-2255 (2004).
30. Hayward, S. Structural principles governing domain motions in proteins. Proteins 36, 425-435 (1999).
31. Coll, R. J. & Murphy, A. J. Purification ofthe CaAT Pase of sarcoplasmic reticulum by affinity chromatography. J. Biol. Chem. 259, 14249-14254 (1984).
32. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
33. Brünger, A. T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
34. Murshudov, G. N., Vagin, A. A., Lebedev, A., Wilson, K. S. & Dodson, E. J. Efficient anisotropic refinement ofmacromolecular structures using FFT. Acta Crystallogr. D 55, 247-255 (1999).
35. Phillips, J. C. et al. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781-1802 (2005).
36. MacKerell, A. D. Jr et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 102, 3586-3616 (1998).
37. Klauda, J. B. et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J. Phys. Chem. B 114, 7830-7843 (2010).
38. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
39. McDonald, I. K. & Thornton, J. M. Satisfying hydrogen bonding potentialinproteins. J. Mol. Biol. 238, 777-793 (1994).
40. Kraulis, P. J. MOLSCRIPT:aprogramtoproduce bothdetailedandschematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).
41. Babu, G. J., Bhupathy, P., Carnes, C. A., Billman, G. E. & Periasamy, M. Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology. J. Mol. Cell. Cardiol. 43, 215-222 (2007).
42. Ohnoki, S. & Martonosi, A. Purification and characterization of the proteolipid of rabbit sarcoplasmic reticulum. Biochim. Biophys. Acta 626, 170-178 (1980).